Sign up for Table of Contents Alerts.
Email this page
Print this page
Editor's Corner
Cover Image
NA
volume 1 | issue 2
March/April 2002Pages: NA A PDF is not yet available for this article.
The use of an antiangiogenic agent to inhibit tumor growth can lead to problems with wound healing. Haroon et al. find a highly significant reduction in granulation tissue (shown) associated with the use of the VEGF receptor selective tyrosine kinase inhibitor SU5416. Also see Commentary by McCarty and Ellis.
A PDF is not yet available for this article.